Rep. Gus M. Bilirakis

Maddy summaryThis bill amends U.S. immigration law to automatically bar immigrants from entering the country and require their removal if they have been convicted of, admitted to committing, or are charged with sexual assault. It directly affects non-citizens (aliens) who have been involved in sexual assault offenses, as defined under existing law. Key provisions add new grounds for inadmissibility (preventing entry) and deportability (requiring removal) specifically for such offenses under sections 212(a)(2) and 237(a)(2) of the Immigration and Nationality Act. The bill does not change criminal penalties for sexual assault but modifies immigration consequences for those with such convictions or admissions.

Maddy summaryHR 3277, the Energy Emergency Leadership Act, reassigns specific energy emergency and security responsibilities to an Assistant Secretary within the Department of Energy. It adds new duties for the Assistant Secretary to handle infrastructure protection, cybersecurity, supply chain issues, and emergency response planning. The bill also authorizes the Department to provide technical assistance to states, local governments, or energy companies upon request when facing energy security threats. This is a procedural bill clarifying existing agency roles, not creating new programs or funding.

Maddy summaryHRES 1054 is a symbolic House resolution recognizing the historical contributions of military animals (such as dogs, horses, and pigeons) and their handlers in U.S. military service since World War I. It acknowledges that these animals, who have served in conflicts and peacekeeping operations, currently lack an official U.S. medal for their bravery. The resolution specifically supports creating a formal annual process to nominate military animals for the "Medal of Bravery" and "Distinguished Service Medal," building on existing efforts by the nonprofit Animals in War & Peace program. This resolution does not create new laws or benefits but formally endorses a process to honor these animals’ service.

Maddy summaryHRES 1031 is a non-binding House resolution declaring the U.S. southern border situation an "invasion," citing three specific claims: over 8 million migrant crossings since 2021, a 1,000% rise in watchlist entries, and drug-related deaths. It does not create new laws or affect individuals, as resolutions like this only express legislative sentiment. The bill formally states the House's viewpoint through these cited statistics without proposing policy changes. As a symbolic gesture, it has no legal force or impact on border policy.

Maddy summaryHR 7455, the Sunset Act of 2024, requires federal agencies to automatically expire significant rules after 10 years unless Congress passes a new law extending them. Agencies must submit reports 180 days before expiration, and Congress can extend rules via joint resolution within 3 legislative days of receiving the report. The bill also mandates annual reviews of 10% of active agency rules for 9 years, with rules not extended by Congress after the 10-year period expiring. It applies to all major agency rules (e.g., environmental or safety regulations) and includes limited presidential exemptions for emergencies, but does not affect existing rules already in effect.

Maddy summaryThis non-binding resolution designates April 5, 2024, as "Barth Syndrome Awareness Day" to raise public awareness about a rare genetic disorder primarily affecting males. It formally supports efforts to improve diagnosis, advance research, and develop treatments for Barth syndrome, which has fewer than 150 diagnosed cases in the U.S. and causes life-threatening heart, muscle, and immune complications. The resolution does not create new laws or funding but recognizes the need for better access to specialized care and regulatory pathways for ultrarare diseases. This symbolic action aims to benefit the small patient community and support the Barth Syndrome Foundation's awareness initiatives.

Maddy summaryHR 7450, the Protecting Privacy in Purchases Act, prohibits payment card networks and covered entities (like payment processors) from requiring or assigning merchant category codes that specifically identify firearms retailers as different from general stores or sporting goods retailers. This directly affects firearms retailers and payment networks by preventing them from using business classification codes that could flag firearm sales. The bill establishes an enforcement process where the Attorney General investigates complaints, issues remediation notices, and can seek court injunctions for non-compliance, while preempting state or local laws on this issue. It does not create private lawsuits for individuals.

Maddy summaryHR 7434, the BEST for Vets Act of 2024, requires that only licensed health care professionals conduct medical disability examinations for veterans' benefits under certain VA pilot programs. The bill amends existing law to prohibit non-licensed personnel from performing these evaluations, ensuring only qualified professionals (as defined in the law) handle disability assessments. It also mandates annual reports to Congress detailing the pilot program's implementation and the VA's compliance actions. This directly affects veterans receiving disability benefits and VA contractors administering medical exams. The law aims to standardize exam quality and transparency in the disability evaluation process.

Maddy summaryHR 7384, the Creating Hope Reauthorization Act of 2024, extends the deadline for issuing priority review vouchers to pharmaceutical companies developing treatments for rare pediatric diseases. The bill amends the Federal Food, Drug, and Cosmetic Act to push the program’s expiration from 2024 to 2028 and adjusts another related deadline to 2030. This directly affects drug manufacturers seeking faster FDA review for new treatments targeting rare childhood illnesses. The extension ensures continued incentives for developing these critical therapies without altering the core voucher mechanism.

Maddy summaryThe RARE Act amends the Federal Food, Drug, and Cosmetic Act to narrow the scope of marketing exclusivity for "orphan drugs" (medications for rare diseases). It changes the rule so that exclusivity applies only to the specific *approved use or indication* of a drug, not the entire rare disease or condition. This means drug companies lose exclusivity for new uses of an already-approved drug within the same rare disease, potentially allowing competitors to develop follow-on treatments faster. The change applies to all orphan-designated drugs, regardless of when they were approved or designated.